In Vivo Biologist- Immunology at Eli Lilly and Company

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, ImmunologyIndustries

Requirements

BS or MS in physiology, biology, pharmacology or closely related field with 2+ years of in vivo experience
Skilled in dose formulation, animal handling, blood collection, animal surgery, and tissue collection/processing
Experienced using Excel and GraphPad Prism for analysis and statistics
Diligent record keeping
Ability to design, analyze, and interpret study results
Good organizational and communication skills; required to present results in internal meetings
Knowledge of molecular biology (e.g., RNA isolation, RT-PCR) preferred
Familiarity with imaging processes (IHC/IF, IVIS, Phenocycler), FACS analysis and FloJo, and/or cell culture techniques preferred

Responsibilities

Perform all aspects of in vivo experiments: dose formulation, animal handling, dosing (PO, IP, SC, ID, IV), blood collection, small animal surgery, and tissue collection/processing, including planning within the pharmacology team
Analyze and graph data for review
Perform ELISAs (or similar platform) on study samples
Organize data and present findings at team meetings
Develop and validate disease models of inflammation and autoimmunity
Conduct in vivo efficacy studies according to study protocols
Handle all aspects of the in-life portions of studies
Perform post-study sample processing and data analysis
Perform in vitro assays of study tissue samples
Work in a team environment and interact with pharmacology group members, immunology members, and cross-functional colleagues

Skills

In Vivo Pharmacology

Small Animal Models

Inflammation Models

Autoimmunity Models

Dosing (PO, IP, SC, ID, IV)

Animal Handling

Dose Formulation

Blood Collection

In Vitro Assays

Sample Processing

Data Analysis

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free